Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07073963 · ClinicalTrials.gov registry record · NA

Virtual Patient Groups for Sarcoidosis Associated Fatigue

A NA study of Depression and Anxiety, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07073963: Recruiting NA study of Depression and Anxiety, sponsored by The Cleveland Clinic.

NCT07073963 is a NA study of Depression and Anxiety that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07073963, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This research study is testing whether Mindfulness-Based Stress Reduction (MBSR) can help reduce fatigue in people with sarcoidosis. The study will also look at whether MBSR can improve symptoms of anxiety and depression. Participants will be placed into one of two groups: * One group will take part in an 8-week virtual MBSR program, attend weekly online sessions, keep a daily mindfulness journal, and complete surveys about fatigue, anxiety, and depression. * The other group will join a virtual support group once a month for 5 months and complete the same surveys. The goal is to see which approach is more helpful for improving fatigue and mental well-being in people with sarcoidosis.

Primary Outcome

validated 8 items fatigue questionnaire reported as an aggregate score

Interventions

  • BEHAVIORAL Virtual Mindfulness Based Stress Reduction Group
  • BEHAVIORAL Virtual sarcoidosis support group

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-02-26
Est. Completion 2028-03-01
Phase NA
The Cleveland Clinic

688 total trials

What NCT07073963 shows while recruiting

NCT07073963 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower).

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Virtual Mindfulness Based Stress Reduction Group is the first listed.

NCT07073963 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07073963 about?

NCT07073963 is a clinical study titled "Virtual Patient Groups for Sarcoidosis Associated Fatigue". This research study is testing whether Mindfulness-Based Stress Reduction (MBSR) can help reduce fatigue in people with sarcoidosis. The study will also look at whether MBSR can improve symptoms of anxiety and depression. Participants will be placed into one of two groups: * One group will take pa...

What is the current status of trial NCT07073963?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-02-26. Estimated completion is 2028-03-01.

What conditions does trial NCT07073963 study?

This clinical trial studies the following conditions: Depression, Anxiety, Fatigue, Mental Health, Sarcoidosis.

What interventions are being tested in trial NCT07073963?

The interventions under investigation include: Virtual Mindfulness Based Stress Reduction Group (BEHAVIORAL), Virtual sarcoidosis support group (BEHAVIORAL).

Who is sponsoring clinical trial NCT07073963?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07073963 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07073963's enrollment target sits among peer trials

100 326th of 679 higher than 331 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07073963, the US trial registry maintained by the National Library of Medicine. NCT07073963 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.